• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Pediatrix Medical Group Inc. (Amendment)

    12/2/22 5:25:24 PM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email
    SC 13D/A 1 sc13da506297280_12022022.htm AMENDMENT NO. 5 TO THE SCHEDULE 13D

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 5)1

    Pediatrix Medical Group, Inc.

    (Name of Issuer)

    Common Stock, par value $0.01 per share

    (Title of Class of Securities)

    58502B106

    (CUSIP Number)

    JEFFREY C. SMITH

    STARBOARD VALUE LP

    777 Third Avenue, 18th Floor

    New York, New York 10017

    (212) 845-7977

     

    STEVE WOLOSKY, ESQ.

    ANDREW FREEDMAN, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    December 2, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 58502B106

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         5,915,000  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              5,915,000  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            5,915,000  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    2

    CUSIP No. 58502B106

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            CAYMAN ISLANDS  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         3,239,643  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              3,239,643  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            3,239,643  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.9%  
      14   TYPE OF REPORTING PERSON  
             
            CO  

      

    3

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE AND OPPORTUNITY S LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         575,327  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              575,327  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            575,327  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    4

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE AND OPPORTUNITY C LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         334,388  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              334,388  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            334,388  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    5

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE R LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         334,388  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              334,388  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            334,388  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    6

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE R GP LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         648,252  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              648,252  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            648,252  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    7

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE AND OPPORTUNITY MASTER FUND L LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            CAYMAN ISLANDS  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         313,864  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              313,864  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            313,864  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    8

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE L LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         313,864  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              313,864  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            313,864  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    9

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD X MASTER FUND LTD  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            CAYMAN ISLANDS  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         457,286  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              457,286  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            457,286  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            CO  

      

    10

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD VALUE GP LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         5,915,000  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              5,915,000  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            5,915,000  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    11

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD PRINCIPAL CO LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         5,915,000  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              5,915,000  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            5,915,000  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    12

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            STARBOARD PRINCIPAL CO GP LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         5,915,000  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              5,915,000  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            5,915,000  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    13

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            JEFFREY C. SMITH  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         5,915,000  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              5,915,000  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            5,915,000  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    14

    CUSIP No. 58502B106

     

      1   NAME OF REPORTING PERSON  
             
            PETER A. FELD  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         - 0 -  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         5,915,000  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              - 0 -  
        10   SHARED DISPOSITIVE POWER  
               
              5,915,000  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            5,915,000  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.1%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    15

    CUSIP No. 58502B106

    The following constitutes Amendment No. 5 to the Schedule 13D filed by the undersigned (“Amendment No. 5”). This Amendment No. 5 amends the Schedule 13D as specifically set forth herein.

    Item 1.Security and Issuer.

    Item 1 is hereby amended and restated to read as follows:

    This statement relates to the Common Stock, par value $0.01 per share (the “Shares”), of Pediatrix Medical Group, Inc., a Florida corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 1301 Concord Terrace, Sunrise, Florida 33323.

    Item 2.Identity and Background.

    Item 2 is hereby amended to add the following:

    (b)       The address of the principal office of each of Messrs. Smith and Feld is c/o Starboard Value LP, 201 E Las Olas Boulevard, Suite 1000, Fort Lauderdale, Florida 33301.

    Item 4.Purpose of Transaction.

    Item 4 is hereby amended to add the following:

    As previously disclosed, Gavin T. Molinelli, a Partner and Portfolio Manager of Starboard Value LP, served as an observer to the Board of Directors of the Issuer (the “Board”). On December 2, 2022, Mr. Molinelli stepped down as an observer to the Board.

    Item 5.Interest in Securities of the Issuer.

    Items 5(a) – (c) are hereby amended and restated to read as follows:

    The aggregate percentage of Shares reported owned by each person named herein is based upon 83,069,757 Shares outstanding, as of October 28, 2022, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2022.

    A.Starboard V&O Fund
    (a)As of the close of business on December 2, 2022, Starboard V&O Fund beneficially owned 3,239,643 Shares.

    Percentage: Approximately 3.9%

    (b)1. Sole power to vote or direct vote: 3,239,643
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 3,239,643
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard V&O Fund has not entered into any transactions in the Shares during the past sixty days.
    16

    CUSIP No. 58502B106

    B.Starboard S LLC
    (a)As of the close of business on December 2, 2022, Starboard S LLC beneficially owned 575,327 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 575,327
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 575,327
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard S LLC has not entered into any transactions in the Shares during the past sixty days.
    C.Starboard C LP
    (a)As of the close of business on December 2, 2022, Starboard C LP beneficially owned 334,388 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 334,388
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 334,388
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard C LP has not entered into any transactions in the Shares during the past sixty days.
    D.Starboard R LP
    (a)Starboard R LP, as the general partner of Starboard C LP, may be deemed the beneficial owner of the 334,388 Shares owned by Starboard C LP.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 334,388
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 334,388
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard R LP has not entered into any transactions in the Shares during the past sixty days.
    E.Starboard R GP
    (a)Starboard R GP, as the general partner of Starboard R LP and Starboard L GP, may be deemed the beneficial owner of the (i) 334,388 Shares owned by Starboard C LP and (ii) 313,864 Shares owned by Starboard L Master.

    17

    CUSIP No. 58502B106

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 648,252
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 648,252
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard R GP has not entered into any transactions in the Shares during the past sixty days.
    F.Starboard L Master
    (a)As of the close of business on December 2, 2022, Starboard L Master beneficially owned 313,864 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 313,864
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 313,864
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard L Master has not entered into any transactions in the Shares during the past sixty days.
    G.Starboard L GP
    (a)Starboard L GP, as the general partner of Starboard L Master, may be deemed the beneficial owner of the 313,864 Shares owned by Starboard L Master.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 313,864
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 313,864
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard L GP has not entered into any transactions in the Shares during the past sixty days.
    H.Starboard X Master
    (a)As of the close of business on December 2, 2022, Starboard X Master beneficially owned 457,286 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 457,286
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 457,286
    4. Shared power to dispose or direct the disposition: 0
    18

    CUSIP No. 58502B106

    (c)Starboard X Master has not entered into any transactions in the Shares during the past sixty days.
    I.Starboard Value LP
    (a)As of the close of business on December 2, 2022, 994,492 Shares were held in the Starboard Value LP Account. Starboard Value LP, as the investment manager of Starboard V&O Fund, Starboard C LP, Starboard L Master, Starboard X Master and the Starboard Value LP Account and the manager of Starboard S LLC, may be deemed the beneficial owner of the (i) 3,239,643 Shares owned by Starboard V&O Fund, (ii) 575,327 Shares owned by Starboard S LLC, (iii) 334,388 Shares owned by Starboard C LP, (iv) 313,864 Shares owned by Starboard L Master, (v) 457,286 Shares owned by Starboard X Master and (vi) 994,492 Shares held in the Starboard Value LP Account.

    Percentage: Approximately 7.1%

    (b)1. Sole power to vote or direct vote: 5,915,000
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 5,915,000
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard Value LP has not entered into any transactions in the Shares during the past sixty days.
    J.Starboard Value GP
    (a)Starboard Value GP, as the general partner of Starboard Value LP, may be deemed the beneficial owner of the (i) 3,239,643 Shares owned by Starboard V&O Fund, (ii) 575,327 Shares owned by Starboard S LLC, (iii) 334,388 Shares owned by Starboard C LP, (iv) 313,864 Shares owned by Starboard L Master, (v) 457,286 Shares owned by Starboard X Master and (vi) 994,492 Shares held in the Starboard Value LP Account.

    Percentage: Approximately 7.1%

    (b)1. Sole power to vote or direct vote: 5,915,000
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 5,915,000
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Starboard Value GP has not entered into any transactions in the Shares during the past sixty days.
    K.Principal Co
    (a)Principal Co, as a member of Starboard Value GP, may be deemed the beneficial owner of the (i) 3,239,643 Shares owned by Starboard V&O Fund, (ii) 575,327 Shares owned by Starboard S LLC, (iii) 334,388 Shares owned by Starboard C LP, (iv) 313,864 Shares owned by Starboard L Master, (v) 457,286 Shares owned by Starboard X Master and (vi) 994,492 Shares held in the Starboard Value LP Account.

    Percentage: Approximately 7.1%

    19

    CUSIP No. 58502B106

    (b)1. Sole power to vote or direct vote: 5,915,000
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 5,915,000
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Principal Co has not entered into any transactions in the Shares during the past sixty days.
    L.Principal GP
    (a)Principal GP, as the general partner of Principal Co, may be deemed the beneficial owner of the (i) 3,239,643 Shares owned by Starboard V&O Fund, (ii) 575,327 Shares owned by Starboard S LLC, (iii) 334,388 Shares owned by Starboard C LP, (iv) 313,864 Shares owned by Starboard L Master, (v) 457,286 Shares owned by Starboard X Master and (vi) 994,492 Shares held in the Starboard Value LP Account.

    Percentage: Approximately 7.1%

    (b)1. Sole power to vote or direct vote: 5,915,000
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 5,915,000
    4. Shared power to dispose or direct the disposition: 0

     

    (c)Principal GP has not entered into any transactions in the Shares during the past sixty days.
    M.Messrs. Smith and Feld
    (a)Each of Messrs. Smith and Feld, as a member of Principal GP and as a member of each of the Management Committee of Starboard Value GP and the Management Committee of Principal GP, may be deemed the beneficial owner of the (i) 3,239,643 Shares owned by Starboard V&O Fund, (ii) 575,327 Shares owned by Starboard S LLC, (iii) 334,388 Shares owned by Starboard C LP, (iv) 313,864 Shares owned by Starboard L Master, (v) 457,286 Shares owned by Starboard X Master and (vi) 994,492 Shares held in the Starboard Value LP Account.

    Percentage: Approximately 7.1%

    (b)1. Sole power to vote or direct vote: 0
    2. Shared power to vote or direct vote: 5,915,000
    3. Sole power to dispose or direct the disposition: 0
    4. Shared power to dispose or direct the disposition: 5,915,000

     

    (c)None of Messrs. Smith or Feld has entered into any transactions in the Shares during the past sixty days.

     

    20

    CUSIP No. 58502B106

    SIGNATURES

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: December 2, 2022

    STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD

    By: Starboard Value LP,

    its investment manager

     

    STARBOARD VALUE AND OPPORTUNITY S LLC

    By: Starboard Value LP,

    its manager

     

    STARBOARD X MASTER FUND LTD

    By: Starboard Value LP,

    its investment manager

     

    STARBOARD VALUE AND OPPORTUNITY C LP

    By: Starboard Value R LP,

    its general partner

     

    STARBOARD VALUE R LP

    By: Starboard Value R GP LLC,

    its general partner

     

    STARBOARD VALUE AND OPPORTUNITY MASTER FUND L LP

    By: Starboard Value L LP,

    its general partner

     

    STARBOARD VALUE L LP

    By: Starboard Value R GP LLC,

    its general partner

     

    STARBOARD VALUE LP

    By: Starboard Value GP LLC,

    its general partner

     

    STARBOARD VALUE GP LLC

    By: Starboard Principal Co LP,

    its member

     

    STARBOARD PRINCIPAL CO LP

    By: Starboard Principal Co GP LLC,

    its general partner

     

    STARBOARD PRINCIPAL CO GP LLC

     

    STARBOARD VALUE R GP LLC

     

     
     
    By:

    /s/ Jeffrey C. Smith

      Name: Jeffrey C. Smith
      Title: Authorized Signatory

     

     
     

    /s/ Jeffrey C. Smith

    JEFFREY C. SMITH
    Individually and as attorney-in-fact for Peter A. Feld

    21

     

    Get the next $MD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Pediatrix Medical Group

    Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

    12/16/24 7:46:05 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Jefferies with a new price target

    Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

    9/26/24 7:37:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

    6/7/24 8:14:20 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Thursday, February 19, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2025. A detailed press release will be issued the morning of February 19, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies

    2/9/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports Third Quarter Results

    Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.84 per share for the three months ended September 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.67. For the 2025 third quarter, Pediatrix reported the following results: Net revenue of $493 million; Net income of $72 million; and Adjusted EBITDA of $87 million. "Our operating results for the third quarter exceeded our expectations and were driven by a combination of reimbursement-related factors, including strong collection activity, higher patient acuity and slightly favorable payor mix, a

    11/3/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Monday, November 3, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2025. A detailed press release will be issued the morning of November 3, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and

    10/21/25 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Ordan Mark S sold $515,430 worth of shares (23,000 units at $22.41), decreasing direct ownership by 7% to 302,805 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    12/17/25 5:00:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Director Rucker Michael A. sold $240,994 worth of shares (10,478 units at $23.00), decreasing direct ownership by 15% to 59,101 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    11/19/25 5:00:13 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Director Linynsky Laura A sold $216,500 worth of shares (10,000 units at $21.65), decreasing direct ownership by 24% to 32,232 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    11/10/25 5:00:05 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    SEC Filings

    View All

    SEC Form 10-Q filed by Pediatrix Medical Group Inc.

    10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    11/3/25 7:00:49 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    11/3/25 6:50:26 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    8/18/25 4:45:29 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Leadership Updates

    Live Leadership Updates

    View All

    Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its board of directors has appointed Kurt D. Newman, M.D., former President and Chief Executive Officer of Children's National Hospital in Washington, D.C. and Professor Emeritus of Surgery and Pediatrics at George Washington University School of Medicine and Health Sciences, as an independent director, effective July 1, 2025. Dr. Newman, a surgeon and nationally recognized leader in pediatric healthcare and a long-term healthcare executive, served as President and Chief Executive Officer of Children's National Hospital for 12 years, after spending over 25 years there as a pediatric sur

    7/1/25 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

    Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

    1/13/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Board Appoints Sylvia Young as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

    5/4/23 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Financials

    Live finance-specific insights

    View All

    Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Thursday, February 19, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2025. A detailed press release will be issued the morning of February 19, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies

    2/9/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports Third Quarter Results

    Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.84 per share for the three months ended September 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.67. For the 2025 third quarter, Pediatrix reported the following results: Net revenue of $493 million; Net income of $72 million; and Adjusted EBITDA of $87 million. "Our operating results for the third quarter exceeded our expectations and were driven by a combination of reimbursement-related factors, including strong collection activity, higher patient acuity and slightly favorable payor mix, a

    11/3/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Monday, November 3, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2025. A detailed press release will be issued the morning of November 3, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and

    10/21/25 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pediatrix Medical Group Inc.

    SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    11/13/24 4:30:24 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    10/31/24 11:54:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    6/10/24 12:43:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care